nifedipine has been researched along with Marfan Syndrome, Type I in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civilibal, M | 1 |
| Calişkan, S | 1 |
| Numan, F | 1 |
| Bariş, S | 1 |
| Doğan, D | 1 |
| Kasapçopur, O | 1 |
| Sever, L | 1 |
| Cantaşdemir, M | 1 |
| Arisoy, N | 1 |
| Syyong, HT | 1 |
| Chung, AW | 1 |
| van Breemen, C | 1 |
2 other studies available for nifedipine and Marfan Syndrome, Type I
| Article | Year |
|---|---|
Renovascular hypertension in a child with Marfan syndrome.
Topics: Adolescent; Angiography, Digital Subtraction; Blood Pressure; Female; Humans; Hypertension, Renovasc | 2010 |
Marfan syndrome decreases Ca2+ wave frequency and vasoconstriction in murine mesenteric resistance arteries without changing underlying mechanisms.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Cations, Divalent; Disease Models, An | 2011 |